Kalvista Pharmaceuticals (KALV) Q4 2024 Earnings

5DecConfirmed
Q1 2024
Q3 2024
Q3 2024
Q4 2024
-1.02
-0.92
-0.82
-0.71

Details

Expected EPS
-0.908
Actual EPS
-0.91
Surprise EPS
-0
Surprise Percent
+0.22%

Description

Kalvista Pharmaceuticals (KALV) has reported earnings of -0.91 per share for Q4 2024.

0 Comments

Share your thoughts